ReposiTrak Posts 16% Revenue Growth, 27% Net Income Increase, and $0.10 EPS for Q3 2025

Reuters
2025/05/20
<a href="https://laohu8.com/S/TRAK">ReposiTrak</a> Posts 16% Revenue Growth, 27% Net Income Increase, and $0.10 EPS for Q3 2025

ReposiTrak Inc., the world's largest food traceability and regulatory compliance network, reported a 16% increase in total revenue for the third fiscal quarter of 2025, amounting to $5.9 million compared to $5.1 million in the same quarter of the previous year. The company highlighted that 98% of this revenue was recurring. Operating expenses for the quarter rose by 7% to $4.1 million, up from $3.8 million last year. Net income for the quarter increased by 27% to $2.0 million, compared to $1.6 million in the third quarter of the prior year. Net income to common shareholders also saw a significant rise of 33%, reaching $1.9 million from $1.4 million the previous year. The company reported a diluted earnings per share $(EPS)$ of $0.10, an improvement from $0.08 in the previous year's third fiscal quarter. ReposiTrak also announced that during the quarter, they redeemed 70,093 preferred shares at a redemption price of $10.70 per share, totaling $749,995, and paid $331,000 in cash dividends to common shareholders. The company ended the quarter with over $28.1 million in cash and no bank debt, demonstrating strong financial stability.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Repositrak Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-017612), on May 19, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10